BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karaiskos I, Galani I, Papoutsaki V, Galani L, Giamarellou H. Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies. Expert Rev Anti Infect Ther 2021;:1-17. [PMID: 34033499 DOI: 10.1080/14787210.2021.1935237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Giacobbe DR, Mirabella M, Rinaldi M, Losito AR, Raffaelli F, Del Puente F, Saffioti C, Mikulska M, Giannella M, Viale P, Tumbarello M, Bassetti M, On Behalf Of Sita Giovani Young Investigators Group Of The Società Italiana Terapia Antinfettiva And The Coli-Cross Study Group. Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study. Antibiotics (Basel) 2021;10:1554. [PMID: 34943767 DOI: 10.3390/antibiotics10121554] [Reference Citation Analysis]
2 Giurazza R, Mazza MC, Andini R, Sansone P, Pace MC, Durante-Mangoni E. Emerging Treatment Options for Multi-Drug-Resistant Bacterial Infections. Life (Basel) 2021;11:519. [PMID: 34204961 DOI: 10.3390/life11060519] [Reference Citation Analysis]
3 De Angelis G, Paggi R, Lowery TJ, Snyder JL, Menchinelli G, Sanguinetti M, Posteraro B, Mencacci A. Direct Testing for KPC-Mediated Carbapenem Resistance from Blood Samples Using a T2 Magnetic Resonance Based Assay. Antibiotics (Basel) 2021;10:950. [PMID: 34439000 DOI: 10.3390/antibiotics10080950] [Reference Citation Analysis]
4 Alfei S, Zuccari G. Recommendations to Synthetize Old and New β-Lactamases Inhibitors: A Review to Encourage Further Production. Pharmaceuticals (Basel) 2022;15:384. [PMID: 35337181 DOI: 10.3390/ph15030384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
5 Principe L, Lupia T, Andriani L, Campanile F, Carcione D, Corcione S, Rosa FGD, Luzzati R, Stroffolini G, Steyde M, Decorti G, Bella SD. Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians. Pharmaceuticals 2022;15:463. [DOI: 10.3390/ph15040463] [Reference Citation Analysis]
6 Bassetti M, Vena A, Giacobbe DR, Castaldo N. Management of Infections Caused by Multidrug-resistant Gram-negative Pathogens: Recent Advances and Future Directions. Arch Med Res 2021;52:817-27. [PMID: 34583850 DOI: 10.1016/j.arcmed.2021.09.002] [Reference Citation Analysis]
7 Carcione D, Siracusa C, Sulejmani A, Leoni V, Intra J. Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use. Antibiotics (Basel) 2021;10:995. [PMID: 34439045 DOI: 10.3390/antibiotics10080995] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pagani N, Corcione S, Lupia T, Scabini S, Filippini C, Angilletta R, Shbaklo N, Mornese Pinna S, Romagnoli R, Biancone L, Cavallo R, Di Perri G, Solidoro P, Boffini M, De Rosa FG. Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection in Solid Organ Transplant Recipients: A Single-Center, Retrospective Study. Microorganisms 2021;9:2272. [PMID: 34835398 DOI: 10.3390/microorganisms9112272] [Reference Citation Analysis]